Using immunofluorescence (IF) staining of tumor sections from EPN and AEP patients, we confirmed the presence of CCL2+ TAMs and CD44+ TAMs as subgroups (Fig. 2e and Supplementary Fig. 3e) and observed higher proportions of these two TAM subsets in AEP (Supplementary Fig. 3d). The gene discussed is CCL2; the disease is neoplasm.